Reviews Urofollitropin Injection


No reviews yet.

Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008




Bravelle Drug Description
BRAVELLE®
(urofollitropin) for Injection, purified
FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION
DRUG DESCRIPTION



What are the possible side effects of urofollitropin (Bravelle)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS). This syndrome may be more likely to occur within the first 10 days after receiving the last dose in a treatment cycle. OHSS can be a life-threatening condition.
Stop using urofollitropin and call your doctor at once if you have any...
Read All Potential Side Effects for Bravelle »




Bravelle® is a product containing a highly purified preparation of human
follicle stimulating hormone (hFSH) extracted from the urine of postmenopausal
women. Human FSH consists of two non-covalently linked glycoproteins designated
as the α and β subunits. The α subunit has 92 amino acids of
which two are modified by attachment of carbohydrates. The β subunit has
111 amino acids of which two are modified by attachment of carbohydrates.
Bravelle® is a sterile, lyophilized powder intended for subcutaneous (SC)
or intramuscular (IM) injection after reconstitution with sterile 0.9% Sodium Chloride Injection, USP. Each vial of Bravelle® contains 82.5 International
Units (IU) of Follicle Stimulating Hormone (FSH) activity, 23 mg Lactose Monohydrate,
0.005 mg Polysorbate 20, and Sodium Phosphate buffer (Sodium Phosphate dibasic,
Heptahydrate and Phosphoric acid) for pH adjustments, which, when reconstituted
with diluent, will deliver 75 IU of FSH. Bravelle® contains up to 2% luteinizing
hormone (LH) activity based on bioassay. Human Chorionic Gonadotropin (hCG)
is not detected in Bravelle®. When stored at 3° to 25°C, up to 40%
of the α-subunits may be oxidized.
The in vivo biological activity of urofollitropin for injection, purified is determined by using reference standards calibrated against the First International Standard for follicle-stimulating hormone, (FSH, Urofollitropin), Urinary, Human for Bioassay, National Institute for Biological Standards and Control (NIBSC) at its 46th meeting in 1995.
FSH is a glycoprotein that is acidic and water-soluble.
Therapeutic class: Infertility.Last reviewed on RxList: 11/18/2008





Other reviews about Urofollitropin Injection on wordpress

fertility
  by as71kumar
Boosting fertility Every couple has a common dream of having a nice child after marriage. Almost every woman wants to be a mother at least once in a lifetime.  […]



Other reviews about Urofollitropin Injection on web:

Consumer information about the medication UROFOLLITROPIN - SUBCUTANEOUS INJECTION (Bravelle, Fertinex, Follistim, Gonal-F), includes side effects, drug interactions, recommended ... UROFOLLITROPIN - SUBCUTANEOUS INJECTION (Bravelle, Fertinex ...


Urofollitropin, FSH Injection To return to the main entry click here . What is Urofollitropin, FSH Injection? UROFOLLITROPIN (Bravelle™, Urofollitropin, FSH Injection: Information from Answers.com


Consumer information about the medication UROFOLLITROPIN - INJECTION (Metrodin), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... UROFOLLITROPIN - INJECTION (Metrodin) side effects, medical uses ...


Urofollitropin, FSH Brand names: Bravelle™Fertinex™ Drug Forms: Urofollitropin, FSH Injection (below) Urofollitropin (FSH) Solution for urofollitropin: Definition from Answers.com


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... St. Luke's Sugar Land Hospital - Your Health Topics


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... Kelsey-Seybold Clinic - Welcome


Urofollitropin, Injection yoor-oh-fol-li-TROH-pin What are other names for this medicine? Type of medicine: gonadotropin; infertility therapy; ovulation stimulator CRS Topic


Learn all about Urofollitropin (Injection). Urofollitropin (ure-oh-FOL-li-troe-pin) Causes the ovaries to release eggs (ovulation) in women who have polycystic ovary disease or a ... Urofollitropin (Injection) - Drug Information


Any urofollitropin that has been prepared for injection (mixed in the syringe) should be used right away. Throw away any unused medicine. Keep all medicine out of the reach of ... Health Library


Urofollitropin (Injection): Urofollitropin (ure-oh-FOL-li-troe-pin)Causes the ovaries to release eggs (ovulation) in women who have polycystic ovary disease or a hormone problem ... Urofollitropin (Injection)





Featured Reviews

Reviews Dana Sota

Who is dana sota? A very nice looking lady, looking more younger than other ladies of her age, with a son of 24 yo, with a great blog (www.danasota.com), where she is suggesting what kind of skin care products you should use. She is very...
Read More  |  Review This
Reviews Diphenhydramine

Benadryl Drug Description BENADRYL® Allergy (diphenhydramine) DRUG DESCRIPTION What are the possible side effects of diphenhydramine? Stop taking diphenhydramine and seek emergency medical attention if you experience an allergic...
Read More  |  Review This
Reviews Levothyroxine Sodium

Levoxyl Drug Description Levoxyl (levothyroxine sodium) Tablet DRUG DESCRIPTION What are the possible side effects of levothyroxine (Levothroid, Levoxyl, Synthroid, Unithroid)? Stop using levothyroxine and get emergency medical...
Read More  |  Review This
Reviews 123flori

www.123flori.ro belongs to one of my friends, Mircea Scarlatescu. After a 2 years experience, hardworking and painstaking, www.123flori.ro became one of the leading flower shops in Romania. As I trust Mircea, i strongly recommend him and...
Read More  |  Review This
Reviews Itraconazole Capsules

Sporanox Drug Description SPORANOX® (itraconazole) Capsules Congestive Heart Failure: SPORANOX ® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....